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Dear Dr. Andoh,
We thank you for the opportunity to respond to the Letter to
the Editor written by Dr. Neel Sharma regarding our recent
publication entitled, ‘‘Diagnostic performance and factors
influencing the accuracy of EUS-FNA of pancreatic neu-
roendocrine neoplasms’’ [1]. We agree with the opinion
expressed by Dr. Sharma that operator training and skill must
be factored into the findings of any study of EUS-FNA.
Skill assessment of operators would assume more rele-
vance when only one or a few operators implement the
procedures. Five expert endosonographers implemented
the procedures or supervised others for the published study.
We feel that having several operators negated the effects of
individual skill variations, and increased the applicability
of the results.
The operators are expected to develop their skills
through experience accumulated through participation in
the study. Two features of the study design minimized any
effects on the results of baseline operator training and
incremental skill gain. One was the presence of on-site
pathological evaluation for all patients. The other was the
division of the study period into periods I (1998–2008; the
first 30 patients) and II (2009–2014; the remaining 28
patients), which would naturally include any changes in
individual skill levels besides variations in equipment and
mechanistic aspects of the procedures over the study per-
iod. Univariate analysis did not select the period as a sig-
nificant factor.
The results for non-experts who undertake these proce-
dures will depend on many factors including the type of
lesion being sampled and the presence or absence of on-site
pathological evaluation as well as other factors. We feel
that trainees should be evaluated by their overall yield of
EUS-FNA as they become more experienced.
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